Cathie Wood’s ARK buys AMD stock, sells CRISPR and Palantir

Cathie Wood’s ARK ETFs have made significant moves in the stock market on Wednesday, April 30th, 2025, with Advanced Micro Devices Inc (NASDAQ:AMD) leading the purchases and CRISPR Therapeutics AG (NASDAQ:CRSP) topping the sales.

In a major bet on the semiconductor industry, ARK ETFs bought a total of 119,118 shares of AMD, valued at approximately $11.4 million. This purchase was distributed between the ARKK and ARKW ETFs, with the former acquiring the lion’s share. The investment reflects ARK’s confidence in AMD’s growth prospects, adding to its recent accumulation of the stock.

On the flip side, ARK reduced its holdings in the gene-editing company CRISPR Therapeutics AG, selling 354,188 shares through its ARKK ETF, resulting in a transaction worth over $13.2 million. This move continues a recent trend of ARK offloading CRSP shares, following sales earlier in the week.

Defense contractor Kratos Defense and Security Solutions Inc (NASDAQ:KTOS) also saw a reduction in ARK’s investment, with a total of 83,126 shares sold across the ARKX (NYSE:ARKX) and ARKQ ETFs, totaling nearly $2.9 million.

Palantir Technologies Inc (NYSE:NASDAQ:PLTR) and Roblox Corp (NYSE:RBLX) were among other notable sales, with ARK divesting 22,380 and 44,746 shares, respectively. The sales of PLTR and RBLX stock were valued at around $2.6 million and $3 million.

In other buying activity, ARK invested in a variety of companies across different sectors. Notably, ARKQ ETF purchased 6,933 shares of heavy machinery manufacturer Caterpillar Inc (NYSE:CAT), totaling more than $2.1 million. Additionally, the ARKW ETF acquired 25,571 shares of software development platform GitLab Inc (NASDAQ:GTLB) for approximately $1.2 million, and 12,632 shares of e-commerce giant Shopify Inc (NYSE:NASDAQ:SHOP) valued at close to $1.25 million.

ARK’s ARKK ETF continued to focus on the healthcare sector, buying 118,73 shares of Natera Inc (NASDAQ:NTRA) and a significant 345,607 shares of Pacific Biosciences of California Inc (NASDAQ:PACB), with the latter transaction amounting to just over $383,000.

Smaller trades included purchases of Blade Air Mobility Inc (NASDAQ:BLDE), Personalis Inc (NASDAQ:PSNL), Symbotic Inc (NASDAQ:SYM), and 10X Genomics Inc (NASDAQ:TXG), with the latter seeing an addition of 184,619 shares by the ARKK ETF, valued at approximately $1.55 million.

Investors keeping a close eye on ARK’s trading patterns will note the consistent interest in the genomic space, with Personalis Inc and 10X Genomics receiving additional investments, suggesting a strategic focus on this innovative field.

Overall, ARK’s trading activity for the day reflects a strategic rebalancing of its portfolio, with significant investments in technology and healthcare while divesting from certain biotech and defense stocks.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.